Indications
| Mesh Heading | Maximum Phase | Reference |
|---|---|---|
| Glioblastoma | Phase 2 | ClinicalTrials |
| Carcinoma; Carcinoma, Renal Cell; Kidney Neoplasms | Phase 3 | ClinicalTrials |
| Glioblastoma; Gliosarcoma | Phase 2 | ClinicalTrials |
| Central Nervous System Neoplasms; Nervous System Neoplasms | Phase 1/Phase 2 | ClinicalTrials |
| Carcinoma, Non-Small-Cell Lung; Lung Neoplasms | Phase 2 | ClinicalTrials |
| Melanoma | Phase 1/Phase 2 | ClinicalTrials |
| Central Nervous System Neoplasms; Nervous System Neoplasms | Phase 2 | ClinicalTrials |
| Carcinoma; Carcinoma, Renal Cell; Recurrence | Phase 2 | ClinicalTrials |
CONTENTS